U.S. black women have lower breast cancer survival

Key points
- Black women with early-stage breast cancer have lower survival rates than their white counterparts even after taking into account variables such as tumor size and socioeconomic differences, researchers said.
- "I think it's due to biological factors in the actual cancer, and this means that race may be a surrogate for a more adverse molecular profile within the cancer," said Dr.
- The study, conducted by the Committee on Special Populations of the Southwest Oncology Group that Albain chairs, used databases from two national clinical trials done in the early 1990s.
- It matched 317 pairs of women - 317 black and 317 white - who had been treated for early-stage breast cancer with chemotherapy and who had been followed after treatment over 10 years.
Black women with early-stage breast cancer have lower survival rates than their white counterparts even after taking into account variables such as tumor size and socioeconomic differences, researchers said.
"I think it's due to biological factors in the actual cancer, and this means that race may be a surrogate for a more adverse molecular profile within the cancer," said Dr. Kathy Albain, the study's senior researcher and a professor of medicine at Loyola University Chicago Medical Center.
The study, conducted by the Committee on Special Populations of the Southwest Oncology Group that Albain chairs, used databases from two national clinical trials done in the early 1990s.
It matched 317 pairs of women - 317 black and 317 white - who had been treated for early-stage breast cancer with chemotherapy and who had been followed after treatment over 10 years.
The survival rate of the white women after 10 years was 86 percent compared to 76 percent for the black women.
All the women had the same tumor stage and were treated identically. The potential influence of age, tumor differences, education level and socioeconomic status also was considered.
The study then took into account the fact that black women were more likely to have discontinued treatment early, to have missed appointments or delayed treatment and had lower initial white blood cell counts. But they had the same relative doses of total chemotherapy delivered during treatment.
Even after adjusting for all of these variables, the survival rate of black women remained worse.
"What we learned is that treatment factors do not explain the racial disparities in survival outcome for early breast cancer," Albain told Reuters in a telephone interview.
She said the study highlights the need for research into the genetic makeup of tumors for each patient, and for tailoring treatments to fight more aggressive cancers.
The study was presented late on Friday at the 29th annual San Antonio Breast Cancer Symposium.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsHigh fruit intake during adolescence linked with lower breast cancer risk
Two linked papers in The BMJ this week shed new light on the relation of alcohol and diet with breast cancer and heart disease . The first study reports that high fruit consumption during adolescence may be associated…
13 May 2016
NewsFamily history of breast cancer doesn't mean a poor prognosis for women who develop the disease
A new large study finds that women who are diagnosed with breast cancer and have a family history of the disease face no worse of a prognosis after treatment than other women with breast cancer. The study, which was…
21 May 2015
NewsBreast cancer in young women - unique goals for treatment and research
Breast cancer that occurs in young women is likely to be more aggressive and to require more intensive types of therapy with increased risk of long-term treatment-related toxicities. The unique and significant…
30 April 2015




